⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZYME News
Zymeworks Inc.
Next-Generation Targeted Therapies Reshape Precision Oncology Landscape
prnewswire.com
GTBP
IDYA
ZYME
NVS
REGN
GTBP
IDYA
ZYME
NVS
REGN
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
globenewswire.com
ZYME
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
globenewswire.com
ZYME